Society guideline links: Gestational trophoblastic disease

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International Federation of Gynecology and Obstetrics (FIGO): Update on the diagnosis and management of gestational trophoblastic disease (2015, updated 2018)

Canada

●Society of Gynecologic Oncology of Canada (GOC)/Society of Obstetricians and Gynaecologists of Canada (SOGC): Joint guideline for management of gestational trophoblastic diseases (2021)

United States

●Society of Gynecologic Oncology (SGO): Evidenced-based review and recommendation on epidemiology, diagnosis, and treatment of gestational trophoblastic disease (2021)

●American College of Radiology (ACR): ACR Appropriateness Criteria on gestational trophoblastic disease (2019)

●ACR: ACR Appropriateness Criteria on first trimester vaginal bleeding (2017)

Europe

●European Society for Medical Oncology (ESMO): Clinical practice guidelines on gestational trophoblastic disease – Diagnosis, treatment, and follow-up (2013)

United Kingdom

●Royal College of Obstetricians and Gynaecologists (RCOG): Green-top guideline on the management of gestational trophoblastic disease (2010)

Australia–New Zealand

●New Zealand Guidelines Group (NZGG): Guidelines on gestational trophoblastic disease (2014, revised 2018)

●Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG): Statement for the management of gestational trophoblastic disease (2017)